Technology | 2016.02.06
Gene-Editing Company Editas's Ambitions Rest on Shaky Foundations - MIT Technology Review
| Gene- Editing Company Editas's Ambitions Rest on Shaky Foundations MIT Technology Review Gene- editing firm Editas today became one of the first companies to go public this year, raising $94 million that it hopes to use to develop a technology called CRIPSR-Cas9, which can make very precise changes to DNA, into a powerful new tool for ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]-ambitions-rest-on-shaky-found
